Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02006823 · ClinicalTrials.gov registry record

Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C

A clinical trial of Chronic Hepatitis C, sponsored by Duke University.

Completed
Registry status
20
Enrollment target
2
Study locations

NCT02006823: Completed study of Chronic Hepatitis C, sponsored by Duke University.

NCT02006823 is a study of Chronic Hepatitis C that has completed, run by Duke University. The registered enrollment target is 20 participants, below the 213-participant average among 16 other Chronic Hepatitis C trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02006823, a study of Chronic Hepatitis C, has completed, sponsored by Duke University.

COMPLETED
Registry status
20 participants
Enrollment target
2
Study locations

Study Summary

This study will explore ways to improve the effectiveness of patient Self Management at a time when genetic test results guide new treatments that will dramatically increase the possibility of cure of the hepatitis C virus.The study will also focus on the interactions between provider and patients and the ways that technical work, adaptive work and adaptive leadership foster patient self-management.This proposed 2 year exploratory mixed-methods 12 longitudinal case study will explore patients' and providers' explanations for how and why they engage in technical work, adaptive work, and adaptive leadership and the ways in which these strategies promote or pose barriers to patients' self-management of Chronic Hepatitis C in the context of the new genetic test results and treatments. Specific aims are to: 1: Examine how technical work, adaptive work and adaptive leadership influence patients' perceptions of their likelihood of cure and how this work relates to self-management during 12 to 24 weeks of treatment for Chronic Hepatitis C. Research questions are: 1.1) How do patients describe their interactions with the providers? 1.2) How do these interactions shape patients' perceptions of the likelihood of cure? 1.3) How do patients' understanding of their interactions with the provider promote the use of or pose barriers to self-management during treatment? AIM 2: Describe providers' use of technical work, and adaptive leadership approaches during clinical encounters,to include nurse education visits. Research questions are: 2.1) What technical work, and adaptive leadership approaches do providers use when sharing treatment information with patients during the clinical encounters. 2.2) What explanations do providers give for how and why they use technical work and adaptive leadership approaches? AIM 3: Describe the trajectories of illness perceptions(Control/Cure sub-scale - Illness Perception Scale), symptoms (M.D. Anderson Symptom Inventory) , viral load, and self-

Primary Outcome

Self Management as measured by the Patient Activation Measure which is an measure of their responses. The study team will plot a trajectory line using the Patient Activation Measure across all time points. The team is interested in knowing if this measure changes based on the patients self-management and his/her interaction with the health care provider.

Conditions Studied

Study Locations (2)

North Carolina

  • Duke University Medical Center - Durham
  • Boice Willis Clinic - Rocky Mount

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2012-03
Est. Completion 2014-07
Duke University

1,725 total trials

What the finished NCT02006823 record still lists

NCT02006823 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 213-participant average among 16 other Chronic Hepatitis C trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Chronic Hepatitis C appearing as the primary indexed condition, and to 0 interventions.

NCT02006823 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT02006823 about?

NCT02006823 is a clinical study titled "Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C". This study will explore ways to improve the effectiveness of patient Self Management at a time when genetic test results guide new treatments that will dramatically increase the possibility of cure of the hepatitis C virus.The study will also focus on the interactions between provider and patients a...

What is the current status of trial NCT02006823?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-03. Estimated completion is 2014-07.

What conditions does trial NCT02006823 study?

This clinical trial studies the following conditions: Chronic Hepatitis C.

Who is sponsoring clinical trial NCT02006823?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02006823 being conducted?

This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Hepatitis C

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02006823's enrollment target sits among peer trials

20 15th of 16 higher than 2 of 16 other Chronic Hepatitis C trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Hepatitis C trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02006823, the US trial registry maintained by the National Library of Medicine. NCT02006823 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.